We are live on ! Find out more
SCV

Sands Capital Ventures Portfolio holdings

AUM $614M
1-Year Est. Return 19.92%
This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+19.92%
3 Year Est. Return
+166.76%
5 Year Est. Return
+157.76%
10 Year Est. Return
–
AUM
$663M
AUM Growth
–
Cap. Flow
+$688M
Cap. Flow %
103.72%
Top 10 Hldgs %
98.34%
Holding
13
New
13
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PATH icon
UiPath
PATH
+$231M
2
DASH icon
DoorDash
DASH
+$121M
3
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$107M
4
SNOW icon
Snowflake
SNOW
+$90M
5
ABOS icon
Acumen Pharmaceuticals
ABOS
+$56.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 44.67%
2 Healthcare 35.75%
3 Consumer Discretionary 19.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PATH icon
1
UiPath
PATH
$8.3B
$201M 30.24%
+3,811,779
New +$231M
DASH icon
2
DoorDash
DASH
$94B
$130M 19.57%
+630,217
New +$121M
DICE
3
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$103M 15.55%
+3,148,970
New +$107M
SNOW icon
4
Snowflake
SNOW
$114B
$95.7M 14.44%
+316,576
New +$90M
ABOS icon
5
Acumen Pharmaceuticals
ABOS
$193M
$50.8M 7.66%
+3,417,075
New +$56.9M
KRTX
6
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$32.8M 4.94%
+267,895
New +$30.9M
TSHA icon
7
Taysha Gene Therapies
TSHA
$1.94B
$13.5M 2.04%
+724,873
New +$13.8M
MASS icon
8
908 Devices
MASS
$414M
$10.6M 1.6%
+326,427
New +$11.1M
CADL icon
9
Candel Therapeutics
CADL
$897M
$8.8M 1.33%
+811,737
New +$6.73M
RGEN icon
10
Repligen
RGEN
$9.42B
$6.51M 0.98%
+22,544
New +$5.78M
TARS icon
11
Tarsus Pharmaceuticals
TARS
$3.04B
$5.6M 0.84%
+260,000
New +$6.44M
SPRB
12
Spruce Biosciences
SPRB
$151M
$4.73M 0.71%
+10,493
New +$6.59M
ABSI icon
13
Absci
ABSI
$1.58B
$672K 0.1%
+57,804
New +$1.12M

Similar funds

T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $613M AUM 14.25% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $613M AUM 30.37% 1-Year Est. Return
MKA
M. Kulyk & Associates Decatur, Georgia $613M AUM 22.75% 1-Year Est. Return
CSIA
Conrad Siegel Investment Advisors Harrisburg, Pennsylvania $615M AUM 21.19% 1-Year Est. Return
ATFA
All Terrain Financial Advisors Coon Rapids, Minnesota $615M AUM 30.42% 1-Year Est. Return
AA
Aire Advisors Beverly Hills, California $615M AUM 25.07% 1-Year Est. Return
FWM
Fonville Wealth Management Richmond, Virginia $612M AUM 18.82% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $615M AUM 26.08% 1-Year Est. Return

Sands Capital Ventures's Q3 2021 Portfolio in Review

Q3 2021 is the first quarter with a 13F filing on record for Sands Capital Ventures, which disclosed 13 positions worth $663M. Its ten largest holdings account for 98% of the portfolio.

Its largest position is UiPath: 3,811,779 shares worth $201M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, followed by Healthcare and Consumer Discretionary.

  • Sands Capital Ventures's largest Q3 2021 buy was UiPath: 3,811,779 shares worth $201M.
  • Sands Capital Ventures's ten largest holdings make up 98% of its $663M portfolio in Q3 2021.
  • Sands Capital Ventures disclosed 13 positions in Q3 2021, its first 13F filing on record.

Based on Sands Capital Ventures's 13F filing for Q3 2021, filed 4 Nov 2021.